Brazil announces end to Zika public health emergency

Brazil has declared an end to its public health emergency over the Zika virus, 18 months after a surge in cases drew headlines around the world.

The mosquito-borne virus was not considered a major health threat until the 2015 outbreak revealed that Zika can lead to severe birth defects. One of those defects, microcephaly, causes babies to be born with skulls much smaller than expected.

Photos of babies with the defect spread panic around the globe as the virus was reported in dozens of countries. Many would-be travellers cancelled their trips to Zika-infected places. The concern spread even more widely when health officials said it could also be transmitted through sexual contact with an infected person.

The health scare came just as Brazil, the epicentre of the outbreak, was preparing to host the 2016 Olympics, fuelling concerns the Games could help spread the virus. One athlete, a Spanish wind surfer, said she got Zika while training in Brazil ahead of the Games.

In response to the outbreak, Brazil launched a mosquito-eradication campaign. The health ministry said those efforts have helped to dramatically reduce cases of Zika. Between January and mid-April, 95% fewer cases were recorded than during the same period last year. The incidence of microcephaly has fallen as well.

The World Health Organization (WHO) lifted its own international emergency in November, even while saying the virus remained a threat.

“The end of the emergency doesn’t mean the end of surveillance or assistance” to affected families, said Adeilson Cavalcante, the secretary for health surveillance at Brazil’s health ministry. “The health ministry and other organisations involved in this area will maintain a policy of fighting Zika, dengue and chikungunya.”

All three diseases are carried by the Aedes aegypti mosquito.

But the WHO has warned that Zika is “here to stay,” even when cases of it fall off, and that fighting the disease will be an ongoing battle.

Brazil announces end to Zika public health emergency

Mylan announces cheaper generic EpiPens amid price-gouging accusations

Mylan says it will make available a generic version of its EpiPen, as criticism mounts over the price of its injectable medicine.

The company said on Monday that its US subsidiary will put out a generic version of the EpiPen that will have a list price of $ 300 for a two-pack – about half the current price. It will be available in both 0.15mg and 0.30mg strengths.

The company charges $ 608 for a two-pack of the branded EpiPen. Mylan said it will keep in place the $ 300 savings card for the branded EpiPen and the revised patient assistance program announced last week.

Consumers and politicians have accused the company of price-gouging, considering that the product has been on the market since 1987 and the price didn’t start rising significantly until Mylan acquired it in 2007. There is also little competition, with the only rival product being Adrenaclick, which carries a list price of $ 461.

Mylan chief executive Heather Bresch has defended the price hikes, saying the company only received $ 274 of the total price for a twin-package while insurers, pharmacies and other parties divvy up the rest.

EpiPens are used in emergencies to treat severe allergies to insect bites and foods like nuts and eggs that can lead to anaphylactic shock. People usually keep a number of EpiPens handy at home, school or work. The syringes, prefilled with the hormone epinephrine, expire after a year.

Mylan said it anticipated having the generic versions available in the next several weeks. It will continue to market and distribute a branded EpiPen.

Numerous members of Congress and other politicians this week have called for congressional hearings on Mylan’s pricing, an investigation by the Federal Trade Commission and action by the Food and Drug Administration to increase competition by speeding up approvals of any rival products.

At least two companies are trying to get US approval to sell a rival brand or generic version of EpiPen. None is likely to hit the US market until well into next year. Relief could come sooner from Imprimis Pharmaceuticals, a compounding pharmacy that prepares medicines to fill individual prescriptions. It said it might be able to sell a version in a few months and would probably charge around $ 100 for two injectors.

Last week, the actress Sarah Jessica Parker terminated her role as a spokesperson for Mylan.

Mylan announces cheaper generic EpiPens amid price-gouging accusations

Google announces wise get in touch with lens partner

The chip and sensor are embedded among two layers of soft get in touch with lens material. A pinhole in the lens enables tear fluid from the surface of the eye to seep into the glucose sensor, which can measure glucose levels when a 2nd.

^{The layers of electronics embedded inside the lens}

The lenses are not anticipated to go on consumer sale for at least 5 many years, Google has mentioned.

In April the company filed a US patent for embedding microscopic cameras into make contact with lenses, enabling the wearer to take images of their direct line of vision.

The patent in depth how wearers will be capable to management the camera via a sophisticated program utilizing the owner’s distinctive blinking patterns, according to Patent Bolt.

Every lens could be designed to incorporate several small camera elements and sensors which could be programmed to detect light, colour, specific objects, faces and movement without having obstructing the vision of the wearer.

The device could be potentially existence-modifying for blind users, as the camera and analysis components could method image data to establish the wearer is approaching a busy road, for instance.

The lens could then problem a command to a remote device, such as a smartphone, to omit a voice-produced warning about the impending road.

“Our dream is to use the most current engineering in the miniaturisation of electronics to help enhance the good quality of daily life for hundreds of thousands of men and women,” said Google co-founder Sergey Brin. “We are really enthusiastic to perform with Novartis to make this dream come real.”

Jeff George, division head of Alcon, mentioned the two firms shared a deep and common passion for innovation.

“By combining Alcon’s leadership in eye care and experience in speak to lenses and intraocular lenses with Google’s revolutionary ‘smart lens’ technology and groundbreaking pace in analysis, we aim to unlock a new frontier to jointly tackle the unmet healthcare needs of hundreds of thousands of eye care sufferers close to the planet,” he explained.

Google announces wise get in touch with lens partner

Simon Stevens announces program to give patients money for care - your views

Billions of lbs of NHS and town hall budgets are to be handed above to sufferers to pick health and social care services in the neighborhood, in a dramatic modify of policy getting unveiled by the new NHS England chief executive.

Simon Stevens advised the Guardian that “north of 5 million sufferers” could every single have a individual combined wellness and social care spending budget by 2018, paid for by “billions” of lbs supplied by the NHS and local councils.

The move will see older folks, disabled young children and these with significant mental well being difficulties or finding out disabilities supplied person pots of cash to devote as they see fit on well being and social care companies, in an attempt, in element, to preserve them out of hospital.

Some patients’ budgets, from subsequent April, will be as small as a few hundred pounds, however most are probably to get more than £1,000, with a tiny variety who have extremely complex demands obtaining much more than that.

What do you consider? Can it work? Will the move alleviate pressure on hospitals? Ought to sufferers have more management above their care? Or, ought to there be a lot more investment in solutions? Share your thoughts in the comment part beneath or tweet us @GdnHealthcare

Simon Stevens announces program to give patients money for care - your views

NHS chief announces plan to give patients income to fund their very own care

Billions of lbs of well being services and town hall budgets are to be handed above to the most vulnerable patients to acquire overall health and social care services in the local community, in a dramatic modify of policy being unveiled by the NHS’s new boss.

Frail elderly individuals, disabled children and people with significant mental illness or understanding disabilities will from next April be offered personal pots of funds to commit as they see match on well being and social care solutions such as carers, physiotherapists and psychotherapy sessions, in an attempt, in portion, to maintain them out of hospital.

Some patients’ budgets will be as tiny as a handful of hundred pounds, though most are probably to get a lot more than £1,000, with a little quantity who have really complex wants receiving significantly more than that. Simon Stevens, NHS England’s chief executive, stated that it would assist maintain folks out of hospital and in the end save income.

These allocated the money would still get free GP and hospital care. Individuals will not instantly receive funds payments into their financial institution accounts but will manage the spending budget, which will be provided right after a care prepare is agreed with their physicians.

Stevens said that “north of five million sufferers” could each and every have a personal mixed health and social care budget by 2018, paid for by “billions” of lbs supplied by the NHS and local councils.

Stevens mentioned the dramatic extension of patient electrical power is needed to aid guarantee individuals get a far better deal from providers many find frustrating to deal with, reduce needless stays in hospital by trying to keep them healthier while nonetheless living at property, and also to conquer the shortages of cash which are increasingly visible in the NHS and social care.

“We are going to set out the largest supply to deliver wellness and social care collectively that there is been given that 1948 – a new alternative for combining them at the degree of the person,” Stevens informed the Guardian as he prepared to outline his ambitious prepare in a speech to council leaders at the Nearby Government Association’s annual conference in Bournemouth. It is his initial main policy alter since taking in excess of in April.

The initiative is driven by “a widespread sense that our Balkanised wellness and social care companies are no longer fit for purpose”, Stevens mentioned, specially when the ageing population has created developing demands for care just when Whitehall austerity programmes have produced what he has known as “two leaky buckets”.

Diminished funding for councils has led to a reduction in the availability of services which traditionally have assisted the elderly stay away from ending up in hospital, as evidenced by a 124% rise in the final 14 years in the variety of mostly older folks needing to be admitted for a day or two as an emergency, he said.

The move is meant to increase the high quality of care the 4 patient groups receive due to the fact at existing as well a lot of of them receive inadequate and “fragmented” care. That transpires simply because wellness and social care providers frequently do not perform properly together and also due to the fact the NHS is not as great as it ought to be in offering sufferers with complicated health care wants the joined-up care they require, he stated.

Older men and women with a number of distinct long-term circumstances can become baffled and daunted by dealing with an array of distinct parts of the NHS, including many departments of the same hospital.

Providing individuals direct handle in excess of these sums of funds is a lot more probably to force overall health and social care solutions to give much more joined-up and consumer-friendly solutions than people two separate techniques being merged, he stated, in a tacit rejection of the “whole particular person care” policy championed by Labour’s shadow health secretary, Andy Burnham.

“Rather than arguing for a structural reorganisation, if Beveridge was alive these days he’d clock the truth that, provided half a opportunity, men and women themselves can be the best ‘integrators’ of the wellness and social care they are provided,” Stevens extra.

In his speech on Wednesday Stevens will make clear that his technique is entirely various to his predecessor Sir David Nicholson’s habit of telling the complete NHS to employ one particular set policy. The new budgets will only be created accessible if neighborhood councils and GP-led NHS clinical commissioning groups in England agree to operate collectively and fund them, he mentioned.

While participation will be voluntary, he expects the two types of bodies to set aside their typical mutual suspicion in excess of which of them must pay out for what aspects of especially needy people’s care wants and make the budgets a reality.

“The proposition that we as NHS England are going to place on the table is that for these neighborhood authorities and neighborhood CCGs that want to operate with us, we will jointly develop combined, blended wellness and social care budgets for named folks in each area”, Stevens explained.

The Neighborhood Government Association and Age United kingdom last evening welcomed Stevens’s strategy in principle.

Katie Hall, chair of the LGA’s neighborhood wellbeing board, said the 648,000 people who have individual budgets to help pay out for their social care requirements had got higher choice and observed their lives enhanced as a consequence. Today’s announcement extends that to overall health requirements as nicely.But whilst council leaders will investigate with NHS England methods to make care more personalised, the new budgets “will not resolve the structural problems in the overall health and care program or fix the funding crisis in social care”, she warned.

Caroline Abrahams, Age UK’s charity director, said: “At the second negotiating the separate health and social care systems is for older individuals puzzling, frustrating and slow, because they have to deal with as well many people and hold telling their story to distinct individuals. For older people these personal budgets could indicate getting the assistance they need to have, tailored to their wants, stop duplication and boost their quality of lifestyle.”

However, the integrated personalized budgets will need to be designed so that they do not “current puzzling choices for some vulnerable older men and women struggling with sickness or dementia” or make individuals feel pressurised into taking one particular up, she additional.

Councillor Jim Dickson, Lambeth council’s cabinet member for health and wellbeing, explained that while most councils would welcome the enhance to integrated care, “the vital check of regardless of whether this will work is of program whether or not there is sufficient money in the new private budgets to supply high quality care”

Jeremy Hunt, the well being secretary, welcomed the plan.

“Greater out of hospital care is crucial for each individuals and the prolonged-term sustainability of NHS,” said a spokesman for Hunt.

NHS chief announces plan to give patients income to fund their very own care

FDA Announces Proposed Regulation Of E-Cigarettes

Nowadays the Food and Drug Administration (FDA) lastly announced proposed regulations for e-cigarettes, responding to strain from public health advocates.

The well-liked liquid nicotine vaporizing units have come under fire for their appeal to little ones and teens and for the poisoning danger posed by the liquid nicotine they incorporate. An additional issue is regardless of whether the wellness benefits presented to smokers attempting to quit have been oversold.

“Tobacco remains the top lead to of death and disease in this country,”  FDA Commissioner Margaret A. Hamburg, MD, explained in her announcement. “This is an important moment for customer protection and a significant proposal that if finalized as written would carry FDA oversight to a lot of new tobacco products.”

Calls for regulation have mounted because the CDC released information displaying that poisonings from the liquid nicotine contained in e-cigarettes rose from one a month in 2010 to 215 a month in February 2014.

Final week, Senator Sherrod Brown (Dem-Ohio) launched a 43-page report, Gateway to Addiction? detailing advertising efforts by e-cigarette organizations that appear to target mostly youngsters and teens.

The report, based on survey information provided by the leading eight makers of e-cigarettes, which [Lorillard (Blu), NJOY,  Reynolds (Vuse), Altria (MarkTen), LOGIC,  VMR Items (V2, Vapor Couture), Eonsmoke, GreenSmoke], uncovered that six of the eight companies add fruit and candy-kind flavorings that make e-cigarettes a lot more well-liked with junior large and substantial college kids.

Many companies also said they sponsored occasions like the well-liked music festival Bonnaroo and a lot of have social media campaigns featuring cartoons and other pictures that seem suspiciously youth-oriented. (Don’t forget “Joe Camel”?)

The proposed restrictions on e-cigarettes incorporate:

• No revenue of e-cigarettes to minors, with vendors essential to demand ID and evidence of age


• Package labels warning that e-cigarettes incorporate nicotine, and that nicotine is addictive


• Well being warnings


• No vending machine sales except grownup-only services


• No free samples – and undoubtedly no cost-free samples to children


• No claims of diminished chance (as opposed to smoked and chewed tobacco) unless of course scientifically confirmed

As Hamburg place it: “Science-based product regulation is a strong kind of customer safety that can help lessen the public well being burden of tobacco use on the American public, such as youth.”

What was missing from the restrictions:

• Outlawing Television and internet marketing and on the web revenue, lengthy demanded by opponents


• Banning on sweet flavorings, which several argue are additional to boost youth appeal

Public overall health advocates, who’ve been incensed by the lack of restrictions on e-cigarettes in specific as regards their burgeoning use by youngsters and teens, welcomed the announcement but said it didn’t go far sufficient.

Well being advocates are concerned about the function that e-cigarettes may possibly play in glamorizing smoking to little ones and teenagers. In March, JAMA, the journal of the American Healthcare Association, published a review displaying that little ones who experiment with e-cigarettes are far more probably than other kids to go on to smoke cigarettes.

The FDA invites public comment on the proposed rule for the subsequent 75 days. In distinct, the FDA explained it was “seeking solutions to the several public well being questions” posed by e-cigarettes and other smokeless tobacco merchandise. Do you have thoughts? Share your suggestions with the FDA and in the comments under.

For a lot more wellness news, stick to me here on Forbes.com, on Twitter, @MelanieHaiken, and subscribe to my posts on Facebook.

FDA Announces Proposed Regulation Of E-Cigarettes

Jeremy Hunt announces "single biggest change" to NHS

Overall health Secretary Jeremy Hunt mentioned that hundreds of thousands of patients are going to be able to see their household medical professionals outside of work hours thanks to a new fund to lengthen GP opening times.

The £50 million GP Entry Fund will suggest that patients at 1,147 GP practices across England will be able to see their family members physician outdoors of operating hours, such as late evening and weekend appointments or use one particular of the modern day consultation resources for convenience.

Mr Hunt set out the proposals for the new funds pot and the Transforming Primary Care programme to help “proactive, personalised care in the community”, which will mostly advantage the elderly.

He explained: “Moving almost a million people onto proactive care strategies is one particular of the biggest adjustments that we need to have to make in our NHS.

“People want to know that their mother and father and relatives will get continuous care if they have a long-phrase situation. Numerous medical professionals previously give fantastic care but I want to make sure this is totally coordinated to head off problems and keep men and women from going to hospital unnecessarily.”

Jeremy Hunt announces "single biggest change" to NHS

FDA Announces Certified Overall health Claims for Omega-three Fatty Acids

The Food and Drug Administration (FDA) these days announced the availability of a competent wellness declare for reduced risk of coronary heart ailment (CHD) on conventional foods that have eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) omega-three fatty acids.

Normally, EPA and DHA omega-three fatty acids are formed in marine phytoplanktonand are very best consumed living and raw. These fatty acids are not essential to the diet regime even so, scientific proof indicates that these fatty acids might be advantageous in decreasing CHD.

“Coronary heart ailment is a important well being dilemma that brings about 500,000 deaths annually in the United States,” said Dr. Lester M. Crawford, Acting FDA Commissioner. “This new experienced health declare for omega-3 fatty acids must assist buyers as they perform to enhance their overall health by identifying meals that incorporate these crucial compounds.”

A certified health claim on a typical food should be supported by credible scientific proof. Based on a systematic evaluation of the available scientific data, as outlined in FDA’s “Interim Procedures for Qualified Overall health Claims in the Labeling of Typical Human Foods and Human Dietary Supplements”, FDA is announcing a experienced overall health claim for EPA and DHA omega-three fatty acids. While this research is not conclusive, the FDA intends to workout its enforcement discretion with respect to the following experienced health declare:

In 2000, FDA announced a comparable competent wellness declare for dietary dietary supplements containing EPA and DHA omega-three fatty acids and the diminished chance of CHD. FDA recommends that shoppers not exceed much more than a total of three grams per day of EPA and DHA omega-3 fatty acids, with no much more than 2 grams per day from a dietary supplement.

The EPA and DHA omega-three fatty acid certified well being claim is the second competent health declare that FDA has announced for traditional food. For extra details about QHC go to: http://www.cfsan.fda.gov/~dms/lab-qhc.html.

FDA Announces Certified Overall health Claims for Omega-three Fatty Acids

Coalition announces inquiry into Indigenous alcohol harm

The Abbott government has set up a parliamentary inquiry into the dangerous use of alcohol in Indigenous communities.

Indigenous affairs minister Nigel Scullion mentioned governments at all amounts have to unite to tackle the epidemic of alcohol abuse “or risk condemning these communities to a lifestyle of alcohol-fuelled poverty”.

“This inquiry will emphasis on very best practice to shape plans and practices that will reduce the scourge of alcohol in Indigenous communities,” he mentioned in a statement.

The decrease house’s standing committee on Indigenous affairs will look into what aspects contribute to hazardous consuming across Indigenous communities and ways to minimise alcohol-connected harm.

The committee’s chair, Liberal MP Sharman Stone, explained the inquiry was not singling out Aboriginal and Torres Strait Islander people as the only group that has issues with alcohol.

But she stated there is concern those in the community who do drink, do so at riskier levels that have greater well being-connected impacts.

The Northern Territory’s shadow minister for Indigenous affairs criticised the inquiry when it was very first proposed in January. Ken Vowles termed the inquiry “insulting” and “disgusting”.

Submissions to the inquiry are due by 17 April.

In a separate advancement, on Thursday it was announced bars in Darwin had agreed to restrict the variety of drinks patrons can purchase in a bid to lessen alcohol-associated violence in the city.

Underneath the Australian Hotels Association initiative, member bars agreed to restrict drinks to four per consumer during happy hours and soon after midnight, and to ban shots soon after 1am.

Shots with an alcohol material of far more than 51% will be banned altogether.

“It’s important we’re witnessed as part of the remedy and not just element of the issue,” explained Mick Burns, senior vice president of the AHA NT.

For the past year chief minister Adam Giles has refused to employ a Newcastle-sort answer to alcohol-associated violence in the NT, and advised an AHA awards dinner last year that the NT’s drinking culture was a “core social value”.

He denied his government was also shut to the liquor sector.

“Darwin is not Newcastle, it is not Kings Cross, it is not Wollongong, “ he informed reporters on Thursday.

“We don’t want to be a government of a nanny state that puts in area rules without having working in cooperation with regional individuals.”

The new regulations apply only to the Darwin city centre, and there are no strategies to roll it out across the rest of the Territory.

Lord mayor Katrina Fong Lim mentioned Darwin’s night-time economic system was well worth $ 444m a year and “it’s quite important that men and women participate” in it.

The NT government has pointed to statistics exhibiting that per capita, alcohol consumption in 2012-13 was 4% less than the preceding year, and that wholesale provide dropped two%.

Coalition announces inquiry into Indigenous alcohol harm

NHS hospitals will have duty to report FGM, government announces

Jane Ellison, the public well being minister, mentioned the move would help guarantee girls and women who had undergone FGM could be cared for. Photograph: Lucy Young/Rex

All NHS acute hospitals are to be obliged to give information on individuals who have undergone female genital mutilation, the government has explained.

Thursday’s announcement, produced to mark the UN’s day of zero tolerance to FGM, comes the day after the Guardian launched a significant campaign in partnership with the 17-year-previous Bristol pupil Fahma Mohamed and Modify.org to finish the practice.

The objective of the new obligation on hospitals is to supply much more info on the prevalence of FGM than ever ahead of, the government said. From September, all hospitals will be required to record if a patient has had FGM, if there is a family members history of the practice or if deinfibulation, which is an FGM-connected method, has been carried out on a female. The data will have to be reported to the Department of Overall health each and every month.

The public wellness minister, Jane Ellison, stated: “Female genital mutilation is an abhorrent practice that has no area in this – or any other – society.

“In purchase to fight it and ensure we can care appropriately for the women and ladies who have undergone mutilation we need to create a far more exact nationwide image of the challenge. This is the initial phase towards undertaking that.”

The government also announced that charities are getting invited to bid for up to £10,000 to carry out neighborhood engagement work aimed at raising awareness of FGM. This follows a productive House Workplace bid for funding from the European commission, enabling it to launch the £100,000 initiative.

The crime prevention minister, Norman Baker, is to chair a cross-government ministerial roundtable on Thursday to discuss operate to finish FGM. He mentioned: “I am determined we do all we can to deliver perpetrators to justice. The law in this country applies to completely every person and political or cultural sensitivities have to not get in the way of avoiding, uncovering and prosecuting those who instigate and carry out FGM.”

A consortium of anti-FGM campaigners set up by the government will assistance efforts by politicians and grassroots activists in Africa to finish the practice. The global advancement minister Lynne Featherstone stated: “We will not see an finish to FGM in the Uk unless of course the practice is eradicated around the world.”

The Guardian campaign is calling on the education secretary, Michael Gove, to send urgent advice to schools on tackling FGM ahead of possibly thousands of women are taken abroad in the summer holidays to be “minimize”.

NHS hospitals will have duty to report FGM, government announces

American University of Cardiology Announces Late-Breaking Clinical Trials

The American School of Cardiology announced the lineup of late-breaking clinical trials for its approaching yearly meeting in Washington, DC. The opening session will incorporate the most eagerly anticipated trials– the main outcomes of  Symplicity HTN-three and the  comparison of Corevalve and surgical procedure in substantial threat sufferers. Subsequent sessions will include many phase 3 trials of  PCSK9 inhibitors. Right here is the total record of trials:

ACC.14 Opening Showcase and the Joint ACC/JACC Late-Breaking Clinical Trials

• March 29, 2014, eight:00 – ten:00 AM


• Chair: John Gordon Harold


• Panelists: Valentin Fuster. David E. Kandzari. Sanjay Kaul. Michael J. Mack

9:ten – 9:25 AM 451-13 - A Randomized Comparison of Self-expanding Transcatheter and Surgical Aortic Valve Substitute in Individuals with Significant Aortic Stenosis Deemed Higher-Risk for Surgical procedure

• David H. Adams, Michael J. Reardon, Steven J. Yakubov, Joseph S. Coselli, G. Michael Deeb, Thomas G. Gleason, Maurice Buchbinder, Blase Carabello, James Hermiller, Jr., Patrick W. Serruys, Neal S. Kleiman, Stanley Chetcuti, John Heiser, William Merhi, George Zorn, Peter Tadros, Newell Robinson, George Petrossian, G. Chad Hughes, J. Kevin Harrison, John Conte, Jae K. Oh, Jeffrey J. Popma, Mount Sinai Healthcare Center, New York, NY, USA

9:35 – 9:50 AM 451-15 - The Principal Benefits of SYMPLICITY HTN-three

• Deepak L. Bhatt, David Kandzari, William O’Neill, Ralph D’Agostino, Murray Esler, John Flack, Barry Katzen, Martin Leon, Minglei Liu, Laura Mauri, Manuela Negoita, Suzanne Oparil, Krishna Rocha-Singh, Paul Sobotka, Raymond Townsend, George Bakris, for the SYMPLICITY HTN-3 Investigators, Brigham and Women’s Hospital Heart and Vascular Center, Boston, MA, USA, University of Chicago, Chicago, IL, USA

Joint American University of Cardiology/Journal of the American Medical Association Late-Breaking Clinical Trials

• March 30, 2014, eight:00 – 9:15 AM Hall D (Primary Tent)


• Co-Chairs: Howard C. Bauchner, Prediman K. Shah


• Panelists: Joseph S. Alpert, Roger S. Blumenthal, Jeffrey T. Kuvin, Roxana Mehran, Nathan D. Wong

8:00 – eight:10 AM 402-08 - Result of Inhibition of Lipoprotein-Linked Phospholipase A2 with Darapladib on Ischemic Events in Sufferers with Chronic Coronary Heart Condition: The STABILITY (STabilisation of Atherosclerotic plaque By Initiation of darapLadIb Therapy) Trial

• Harvey D. White, Claes Held, Ralph Stewart, Philippe Steg, Andrzej Budaj, Robert Harrington, Elizabeth Tarka, Rebekkah S. Brown, Christopher Cannon, Lars Wallentin, the STABILITY Investigators., Green Lane Cardiovascular Service, Auckland City Hospital, Auckland, New Zealand, Uppsala Clinical Analysis center, Uppsala, Sweden

8:15 – eight:25 AM 402-ten - The Low-density Lipoprotein Cholesterol Evaluation With PCSK9 Monoclonal Antibody Inhibition Combined With Statin Therapy – 2 Trial: A Phase 3, Double-blind, Randomized, Placebo and Ezetimibe Managed, Multicenter Review to Assess Security, Tolerability and Efficacy of Evolocumab (AMG 145) in Combination With Statin Treatment in Subjects With Primary Hypercholesterolemia and Mixed Dyslipidemia

• Jennifer Robinson, Bettina S. Nedergaard, William Rogers, Jonathan Fialkow, Joel Neutel, David Ramstad, Ransi Somaratne, Jason Legg, Patric Nelson, Robert Scott, Scott Wasserman, Robert Weiss, for the LAPLACE-2 Investigators, Amgen Inc., Thousand Oaks, CA, USA

8:30 – 8:40 AM 402-twelve - Evaluation of the Dual PPAR-αγ Agonist Aleglitazar to Minimize Cardiovascular Occasions in Individuals with Acute Coronary Syndrome and Sort 2 Diabetes Mellitus: the AleCardio Trial

• A. Michael Lincoff, Jean Claude Tardif, Bruce Neal, Stephen Nicholls, Lars Ryden, Gregory Schwartz, Klas Malmberg, John Buse, Robert Henry, Hans Wedel, Arlette Weichert, Anders Svensson, Ruth Cannata, Diederick Grobbee, AleCardio Examine Investigators, Cleveland Clinic, Cleveland, OH, USA

8:45 – eight:55 AM 402-14 - Two-yr End result of a Trial Comparing Second Generation Drug-eluting Stents Making use of Either Biodegradable Polymer or Resilient Polymer: the NOBORITM Biolimus-Eluting versus XIENCETM/PROMUSTM Everolimus-eluting Stent Trial (Up coming)

• Masahiro Natsuaki, Ken Kozuma, Takeshi Morimoto, Kazushige Kadota, Toshiya Muramatsu, Yoshihisa Nakagawa, Takashi Akasaka, Keiichi Igarashi, Kengo Tanabe, Yoshihiro Morino, Tetsuya Ishikawa, Hideo Nishikawa, Masaki Awata, Mitsuru Abe, Hisayuki Okada, Yoshiki Takatsu, Nobuhiko Ogata, Kazuo Kimura, Kazushi Urasawa, Yasuhiro Tarutani, Nobuo Shiode, Takeshi Kimura, Kyoto University, Kyoto, Japan, Saiseikai Fukuoka Common Hospital, Fukuoka, Japan

9:00 – 9:10 AM 402-sixteen - A Phase 3 Double-blind, Randomized Review to Assess the Security and Efficacy of Evolocumab (AMG 145) in Hypercholesterolemic Subjects Unable to Tolerate an Successful Dose of Statin

• Erik S.G. Stroes, David Colquhoun, David Sullivan, Fernando Civeira, Robert Rosenson, Gerald F. Watts, Eric Bruckert, Ricardo Dent, Allen Xue, Robert Scott, Scott Wasserman, Michael Rocco, GAUSS-two Investigators, Amgen Inc., Thousand Oaks, CA, USA

Late-Breaking Clinical Trials III

• March thirty, 2014, ten:45 – 12:00 PM Hall D (Principal Tent)


• Co-Chairs: Rick A. Nishimura, Evan M. Zahn


• Panelists: George L. Bakris, Massimo Imazio, Allan S. Jaffe, Michael Shehata, Ronald G. Victor

ten:45 – 10:fifty five AM 403-08 - Efficacy And Safety Of Colchicine In Patients With Several Recurrences Of Pericarditis: Final results Of A Multicenter, Double-blind, Placebo-managed, Randomized Research (corp-two Trial).

• Massimo Imazio, Riccardo Belli, Antonio Brucato, Roberto Cemin, Stefania Ferrua, Yehuda Adler, David H. Spodick, Rita Trinchero, Cardiology Division, Maria Vittoria Hospital, Torino, Italy

11:00 – eleven:10 AM 403-ten - The Worldwide SYMPLICITY Registry: Security and Effectiveness of Renal Artery Denervation In Actual Globe Individuals With Uncontrolled Hypertension

• Michael Bohm, Markus Schlaich, Krzysztof Narkiewicz, Luis Ruilope, Bryan Williams, Roland Schmieder, Felix Mahfoud, Giuseppe Mancia, Universitätskliniken des Saarlandes, Klinik für Innere Medizin III, Homburg/Saar, Germany

eleven:15 – 11:25 AM 403-12 - A single 12 months Adhere to-up of the Melody Transcatheter Pulmonary Valve Multicenter Publish Approval Review

• Aimee K. Armstrong, David Balzer, Allison Cabalka, Robert Gray, Alexander Javois, Jacqueline Kreutzer, John Moore, Jonathan Rome, Daniel Turner, Thomas Zellers, University of Michigan C.S. Mott Children’s Hospital, Ann Arbor, MI, USA, Children’s Hospital of Pittsburgh, Pittsburgh, PA, USA

eleven:thirty – eleven:40 AM 403-14 - Lengthy-term Survival with Cardiac Resynchronization Treatment in Individuals with Mild Heart Failure

• Ilan Goldenberg, Valentina Kutyifa, Helmut Klein, Scott McNitt, Scott Solomon, Arthur Moss, MADIT-CRT Executive Committee, University of Rochester Health-related Center, Rochester, NY, USA, Sheba Healthcare Center, Tel Hashomer, Israel

11:45 – eleven:55 AM 403-16 - Adverse High-Delicate Troponins in the Emergency Department and Risk of Myocardial Infarction

• Nadia Bandstein, Magnus Johansson, Rickard Ljung, Martin Holzmann, Karolinska Institutet, Stockholm, Sweden

Joint American University of Cardiology/New England Journal of Medicine Late-Breaking Clinical Trials

• March 31, 2014, eight:00 – 9:15 AM Hall D (Primary Tent)


• Co-Chairs: John A. Jarcho, Steven E. Nissen


• Panelists: Yochai Birnbaum, Scott Cunneen, Michael H. Davidson, D. Craig Miller, Freek W. A. Verheugt

eight:00 – eight:10 AM 404-08 - The Influence of Acetyl-Salicylic Acid on Main Arterial and Venous Problems in Patients Undergoing Noncardiac Surgery

• P.J. Devereaux, POISE-two Investigators, Population Health Research Institute, Hamilton, Canada

eight:15 – 8:25 AM 404-ten - A Big Global Trial Assessing the Results of Clonidine on Significant Arterial Events in Individuals Obtaining Noncardiac Surgical treatment

• Daniel I. Sessler, P.J. Devereaux, POISE-2 Investigators, Outcomes Research, Cleveland Clinic, Cleveland, OH, USA

8:30 – 8:40 AM 404-twelve - Steroids in Cardiac Surgical procedure Trial (SIRS)

• Richard Whitlock, Population Overall health Study Institute, McMaster University/Hamilton Overall health Sciences, Hamilton, Canada

eight:45 – 8:55 AM 404-14 - Metformin in Acute Myocardial Infarction

• Chris PH Lexis, Iwan CC van der Horst, Erik Lipsic, Jan Tijssen, Pim van der Harst, Dirk van Veldhuisen, GIPS-III Investigators, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands, Academic Health care Center, University of Amsterdam, Amsterdam, The Netherlands

9:00 – 9:ten AM 404-16 - Effect of Bariatric Surgical procedure vs. Intensive Medical Treatment on Extended-phrase Glycemic Manage and Complications of Diabetes: 3-Year STAMPEDE Trial Final results

• Philip Raymond Schauer, John Kirwan, Kathy Wolski, Stacy Brethauer, Sankar Navaneethan, Ali Aminian, Claire Pothier, Steven Nissen, Deepak Bhatt, Sangeeta Kashyap, Cleveland Clinic, Cleveland, OH, USA

Late-Breaking Clinical Trials V: TCT@ACC-i2

• March 31, 2014, 10:45 – twelve:00 PM Hall D (Major Tent)


• Co-Chairs: Cindy L. Grines, David E. Kandzari


• Panelists: David L. Brown, David E. Kandzari, Dean J. Kereiakes, Roxana Mehran, William W. O’Neill

10:45 – 10:55 AM 405-08 - One Year Outcomes from the STS/ACC Transcatheter Valve Therapy (TVT) Registry

• David R. Holmes, J. Matthew Brennan, John Rumsfeld, Dadi (David) Dai, Fred Edwards, John Carroll, David Shahian, Frederick Grover, E. Murat Tuzcu, Eric Peterson, Ralph Brindis, Michael Mack, Mayo Clinic, Rochester, MN, USA

11:00 – eleven:10 AM 405-10 - A Randomized Comparison of Self-Expandable and Balloon-Expandable Prostheses in Patients Undergoing Transfemoral Transcatheter Aortic Valve Substitute – The Choice Trial

• Mohamed Abdel-Wahab, Julinda Mehilli, Ulrich Schäfer, FJ Neumann, Thomas Kurz, Ralph Toelg, Bettina Schwarz, Ken Gordian, Volker Geist, Steffen Massberg, Christian Frerker, Mohamed El-Mawardy, Gert Richardt, Heart Center, Segeberger Kliniken, Bad Segeberg, Germany

11:15 – eleven:25 AM 405-12 - Unfractionated Heparin versus Bivalirudin in Main Percutaneous Coronary Intervention: A Exclusive Randomized Controlled Trial with Consecutive, Unselected Patient Enrollment (using Delayed Consent), Developed to Reflect True-Planet, Contemporary Practice

• Adeel Shahzad, Ian Kemp, Christine Mars, Rob Cooper, Claire Roome, Keith Wilson, Rod Stables, HEAT-PPCI investigators, Institute of Cardiovascular Medicine and Science, Liverpool Heart and Chest Hospital NHS Believe in, Liverpool, United Kingdom

11:thirty – eleven:40 AM 405-14 - Bare Metal vs. Zotarolimus-eluting stent in Uncertain Drug-eluting Stent Candidates: A Randomized Controlled Trial

• Marco Valgimigli, ZEUS investigators, , Thoraxcenter, Erasmus MC, Rotterdam, The Netherlands

eleven:45 – eleven:fifty five AM 405-16 - Autotransplantation of Bone Marrow Derived Mesenchymal Stromal Cells in Individuals with Extreme Ischemic Heart Failure: The MSC-HF Trial

• Anders Bruun Mathiasen, Abbas Qayyum, Erik Jørgensen, Steffen Helqvist, Anne Fischer-Nielsen, Klaus Kofoed, Mandana Haack-Sørensen, Annette Ekblond, Jens Kastrup, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark, Denmark

American University of Cardiology Announces Late-Breaking Clinical Trials